business transforrmation

Article

Identification of Medicinal Products

Think Transformation

Identification of Medicinal Products (IDMP) is one the biggest regulatory challenges for all pharmaceutical companies operating in Europe. How can your organisation navigate this journey towards increased patient safety and use it as an opportunity for business transformation?

The IDMP imperative

Over the next few years, pharmaceutical organisations will be mandated to electronically submit and maintain product information on an ongoing basis. This new regulation is one the biggest regulatory challenges for pharmaceutical companies in Europe and will drive organisations to make significant changes to their current product-related processes and systems, ushering in a new era of cross-functional collaboration.

IDMP will be a game-changer in terms of using process and technology integration to improve patient safety. IDMP will provide companies with an opportunity to make product data work more effectively from a business perspective via improvements in data quality and usage.

Download the report
Beginning the journey to IDMP readiness

IDMP’s broad and cross-functional scope requires a corporate-wide effort to align on standards, master data management, data governance, and identification of authoritative source systems. This presents a pharmaceutical company with an opportunity to transform how it manages data across the entire lifecycle of a medicinal product.

The first and most crucial step towards achieving IDMP readiness is to understand where the relevant data is residing within the organisation or externally. A thorough and diligent fit-gap analysis can provide a solid understanding of the current state and highlight any gaps that must be bridged to reach compliance.

  • Contact us
  • Submit an RFP
  • Life Sciences & Health care related article

    Life Sciences & Health care

    Leadership perspectives

    The Health Care Current, a weekly series published by the Deloitte US Center for Health Solutions, explores breaking news and developments in the health care industry, examines key issues facing LSHC companies and provides updates and insights on policy, regulatory, and legislative changes.

    2018 Global health care outlook

    With quality, outcomes, and value being the watchwords for health care in the 21st century, sector stakeholders around the globe are looking for innovative and cost-effective ways to deliver patient-centered, technology-enabled “smart” health care, both inside and outside hospital walls.

     

    2018 Global life sciences outlook

    The evolving industrialization of life sciences will affect all aspects of how companies work to meet consumer expectations. Learn more in the outlook for 2018.

Did you find this useful?